Royal London has scaled back its UK earnings forecast, following the BP oil spill, though it believes UK equities look attractive over the longer term.
The manager of the Finsbury Worldwide Pharmaceutical trust believes companies manufacturing generic medicines will continue to outperform the pharma giants.
Paul Marriage's Cazenove Absolute UK Dynamic fund saw performance hit last month when his hedge fund was met with heavy redemptions. Both the retail fund and the hedge fund hold many of the same positions.
Multi-asset manager John Husselbee warns disappointing GDP figures from the US could trigger a dip in equity markets and says he will once again be turning to hedging techniques to protect his portfolios.
BlackRock's Sam Vecht is bullish about the long-term prospects for Russia, arguing there is more to the country's economy than oil.
The new Government has announced plans for a total shake-up of financial services regulation to conclude in 2012, which is also the deadline for IFAs to meet RDR requirements.
Polar Capital's Ben Rogoff has put the 3% cash position in his Technology trust back into the stock market as valuations become compelling after the recent correction.
Aegon UK has denied a report suggesting its Dutch parent is preparing to offload its British life and pensions business for £1.5bn.
Economic sentiment in Germany slid last week following signs the recovery is slowing, according to the Centre for European Economic Research (ZEW) in Mannheim.
PSigma's James Abate says the US market has hit its trough and will not slump further this year, but is likely to see a "huge rally" in the reporting season.